Business Wire

AMADIS

29.9.2020 13:57:09 CEST | Business Wire | Press release

Share
Amadis Leverages Nexo Standards to Simplify Global Payment Acceptance

Amadis , a payment software and consulting services provider, today announced a streamlined path for North American and international merchants to migrate to the nexo global payment standard, the most comprehensive set of global payment acceptance protocols on the market today. By integrating nexo’s messaging protocols, standards and specifications into its Arkos universal payments acceptance software, Amadis provides “plug-and-play” universal payment software that enables customers to quickly accept new payment types, independent of equipment, technology or geography.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200929005023/en/

Amadis has helped a diverse range of banking, retail and transport customers deploy nexo-based applications, enabling customers to future-proof their payment systems, while lowering development time and accelerating time to market. With Amadis’ Arkos product, an EMV middleware that manages all the card acceptance processing, customers can rapidly migrate to nexo and vastly reduce their custom development requirements, enabling companies to substantially reduce time to market, risks and costs for each unique payment solution implementation. Arkos can manage any type of equipment (standalone, PINPads, unattended, mobile) and devices while:

  • Integrating US processing rules (debit network selection; low value payments)
  • Providing central management and reporting
  • Meeting M-TIP, ADVT Pre-certified EMV requirements

“By editing the Amadis Arkos software using nexo protocols, we ensure our clients have the same common interoperable interface and protocol across the globe that breeds innovation at the point of contact,” said Emmanuel Haydont, CEO, and co-founder of Amadis. “By using nexo protocols, we help our customers drastically reduce time to market and cost of ownership, while enabling them to free themselves from unnecessary technical dependencies and provide a pathway that better future-proofs merchants as payments continue to evolve.”

nexo standards is the international association enabling global interoperability in payment acceptance. Its membership is expanding rapidly across continents, with members from several countries including the United States, Canada, China, India, Japan, Russia, and Saudi Arabia, further cementing the global interest in its standards and its truly international reach.

Unlike proprietary solutions that lock companies into using proprietary host interfaces, terminal management systems (TMS), platforms or operating in a certain geography, nexo is an open standard that guarantees multiple interoperabilities: cross border, platform, host, market segment and others. nexo standards enables companies to innovate on top of its specifications and protocols, removing both the significant complexity from the technical integration as well as the implementation challenges companies face as they expand acceptance of new payment types from devices in new markets. The nexo association provides open standards and protocols that guarantee cross-border interoperability.

“Market demand for nexo standards is higher than ever before. In response, active members such as Amadis are making significant progress in their deployment and adoption strategies,” comments Jacques Soussana, Secretary-General at nexo standards. “With the combination of our specifications, protocols, implementation guidelines, collaborative working groups, and testing and certification support, we are providing members with the tools to build and validate their solutions, fast-tracking their path to deployment. The global adoption of nexo standards is fast becoming a reality.”

Amadis’ global customers require payment acceptance solutions that are secure and ensure optimized operations, while allowing for best management of future-proofing needs in the near and long-term. nexo standards is the international association enabling global interoperability in payment acceptance. With the recent global stresses the economy and industries have faced, it has become imperative that solution providers seek out standards such as nexo that allow businesses to operate more efficiently and expand globally.

*EMV ® is a registered trademark in the U.S. and other countries and an unregistered trademark elsewhere. The EMV trademark is owned by EMVCo, LLC

About Amadis

Amadis is a privately-held division of Maxim Integrated. Amadis is a leader in payment software technology, with its software running on more than 10 million devices worldwide. The company provides state-of-the-art software editing and development solutions for global merchants, payment device manufacturers and service providers. Amadis provides merchants with the industry’s broadest range of payment processing options using custom or commercially available technology, independent of hardware or geography. The company brings an elite, experienced software team to the industry and enables solutions for international merchants in over 23 countries. Learn more at www.amadis.ca .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye